BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 29, 2025
Home » Authors » Kim Coghill

Articles by Kim Coghill

Greenwood Named To Take Helm From Feldbaum As Head Of BIO

July 23, 2004
By Kim Coghill
WASHINGTON - U.S. Rep. Jim Greenwood, a Republican from Pennsylvania, retired from Congress Thursday to accept the position as president of the Biotechnology Industry Organization. (BioWorld Today)
Read More

Agensys, Genentech Enter Deal On Cancer Targets, Antibodies

July 23, 2004
By Kim Coghill

Greenwood Named To Take Helm From Feldbaum As Head Of BIO

July 23, 2004
By Kim Coghill
WASHINGTON - U.S. Rep. Jim Greenwood, a Republican from Pennsylvania, retired from Congress Thursday to accept the position as president of the Biotechnology Industry Organization. (BioWorld Today)
Read More

Agensys, Genentech Enter Deal On Cancer Targets, Antibodies

July 23, 2004
By Kim Coghill

ImClone Reports Erbitux Sales Of $71.4M, Plans sBLA Filing

July 22, 2004
By Kim Coghill
ImClone Systems Inc.'s stock fell 18.9 percent Wednesday even though the firm turned a profit on Erbitux sales and said it intends to request FDA approval of the drug in head and neck cancer. (BioWorld Today)
Read More

Seattle Genetics, Celera Join Up For Discovery Of Cancer Drugs

July 22, 2004
By Kim Coghill

ImClone Reports Erbitux Sales Of $71.4M, Plans sBLA Filing

July 22, 2004
By Kim Coghill
ImClone Systems Inc.'s stock fell 18.9 percent Wednesday even though the firm turned a profit on Erbitux sales and said it intends to request FDA approval of the drug in head and neck cancer. (BioWorld Today)
Read More

Seattle Genetics, Celera Join Up For Discovery Of Cancer Drugs

July 22, 2004
By Kim Coghill

FDA Considers Changes To Response Letters For Drugs

July 21, 2004
By Kim Coghill

Depomed Files NDA For Extended-Release Version Of Ciprofloxacin

July 21, 2004
By Kim Coghill
Previous 1 2 … 6 7 8 9 10 11 12 13 14 … 142 143 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 29, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing